MARKET

PTN

PTN

Palatin Tech
AMEX
14.41
-0.52
-3.45%
After Hours: 15.05 +0.64 +4.46% 19:59 05/15 EDT
OPEN
15.00
PREV CLOSE
14.93
HIGH
15.51
LOW
14.15
VOLUME
23.05K
TURNOVER
--
52 WEEK HIGH
31.00
52 WEEK LOW
4.255
MARKET CAP
25.64M
P/E (TTM)
-1.3780
1D
5D
1M
3M
1Y
5Y
1D
Palatin price target lowered to $47.50 from $50 at Alliance Global
TipRanks · 2d ago
Palatin Technologies Earnings Call: Partnerships, Progress, Risks
TipRanks · 2d ago
Transcript: Palatin Techs Q3 2026 Earnings Conference Call
Benzinga · 3d ago
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
TipRanks · 3d ago
Palatin Techs Q3 EPS $(0.37) Beats $(1.26) Estimate, Sales $3.921M Beat $1.283M Estimate
Benzinga · 3d ago
Palatin Technologies GAAP EPS of -$0.37, revenue of $3.9M
Seeking Alpha · 3d ago
*Palatin Technologies: Runway To Fund Operations Through June 2027 >PTN
Dow Jones · 3d ago
*Palatin Technologies 3Q Rev $3.92M >PTN
Dow Jones · 3d ago
More
About PTN
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. The MCR system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Its product development activities focus primarily on the use of MC4R agonists for treatment of obesity. It develops MC4R peptides and small molecule agonists with potential utility in obesity and metabolic-related disorders, rare MC4R pathway diseases, such as hypothalamic obesity, and orphan indications. It also develops MC1R agonist products to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease.

Webull offers Palatin Technologies Inc stock information, including AMEX: PTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTN stock methods without spending real money on the virtual paper trading platform.